These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6786737)

  • 1. Treatment of advanced adenocarcinoma of the lung with ftorafur, doxorubicin, cyclophosphamide, and cisplatin (FACP) and intensive iv hyperalimentation.
    Jordan WM; Valdivieso M; Frankmann C; Gillespie M; Issell BF; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(3-4):197-205. PubMed ID: 6786737
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancer.
    Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK; Coles DT
    Cancer Treat Rep; 1981; 65(7-8):715-7. PubMed ID: 6166376
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung.
    Eagan RT; Frytak S; Creagan ET; Ingle JN; Kvols LK; Coles DT
    Cancer Treat Rep; 1979; 63(9-10):1589-91. PubMed ID: 227597
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lung.
    Eagan RT; Frytak S; Ingle JN; Creagan ET; Nichols WC; Kvols LK
    Cancer Treat Rep; 1980; 64(8-9):925-8. PubMed ID: 7192602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for adenocarcinoma and large cell anaplastic carcinoma of the lung with ftorafur, adriamycin, and cis-dichlorodiammineplatinum(II).
    Issell BF; Valdivieso M; Bodey GP
    Cancer Treat Rep; 1978 Jul; 62(7):1089-91. PubMed ID: 210943
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased therapeutic index of weekly doxorubicin in the therapy of non-small cell lung cancer: a prospective, randomized study.
    Valdivieso M; Burgess MA; Ewer MS; Mackay B; Wallace S; Benjamin RS; Ali MK; Bodey GP; Freireich EJ
    J Clin Oncol; 1984 Mar; 2(3):207-14. PubMed ID: 6321689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin (CHAD) as second-line chemotherapy for ovarian adenocarcinoma.
    Piver MS; Lele S; Barlow JJ
    Cancer Treat Rep; 1981; 65(1-2):149-51. PubMed ID: 6784921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
    Kelsen D; Gralla R; Stoopler M; Casper E; Cheng E; Kosloff C; Golbey R
    Cancer Treat Rep; 1982 Feb; 66(2):247-51. PubMed ID: 7034932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four-drug combination chemotherapy in extensive non-small cell lung cancer: a Southwest Oncology Group Pilot Study.
    Livingston RB; Mira J; O'Bryan RM
    Cancer Treat Rep; 1981; 65(1-2):143-4. PubMed ID: 6164484
    [No Abstract]   [Full Text] [Related]  

  • 10. Intensified nutrition as an adjunct to cytotoxic chemotherapy in gynaecological cancer patients.
    Nuutinen LS; Kauppila A; Ryhänen P; Niinimäki A; Kivinen S; Saarela M; Pakarinen A; Hollmén A
    Clin Oncol; 1982 Jun; 8(2):107-12. PubMed ID: 6809386
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].
    Sanz Ortiz J; Saiz García F
    Med Clin (Barc); 1982 Nov 16-30; 79(9):403-6. PubMed ID: 6296560
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination chemotherapy for advanced carcinoma of the fallopian tube.
    Deppe G; Bruckner HW; Cohen CJ
    Obstet Gynecol; 1980 Oct; 56(4):530-2. PubMed ID: 7191548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of prognostic nutritional index in chemotherapy of lung cancer].
    Nakai Y; Saito J
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):493-6. PubMed ID: 1706172
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemotherapy of advanced breast cancer--actual results ].
    Matthes ML; Lenk H; Gürtler R; Tanneberger S
    Arch Geschwulstforsch; 1982 May; 52(3):241-6. PubMed ID: 6812538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of advanced non-small cell lung cancer.
    Knost JA; Greco FA; Hande KR; Richardson RL; Fer MF; Oldham RK
    Cancer Treat Rep; 1981; 65(11-12):941-5. PubMed ID: 7028255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy following radical surgery for non-small-cell lung cancer: a randomized study on 70 patients.
    Xu G; Rong T; Lin P
    Chin Med J (Engl); 2000 Jul; 113(7):617-20. PubMed ID: 11776031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of 2 different chemotherapeutic combinations in epidermoid carcinoma of the lung. Preliminary results].
    Pipino G; Germiniani R; Maione G; Fazio FM
    Arch Sci Med (Torino); 1983; 140(2):135-8. PubMed ID: 6192792
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.
    Evans WK; Feld R; DeBoer G; Osoba D; Curtis JE; Baker MA; Myers RE; Quirt IC; Pritchard KI; Brown TC; Kutas GJ; Blackstein ME; Ottema B; Millband L
    Cancer Treat Rep; 1981; 65(11-12):947-54. PubMed ID: 7028256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ovarian adenocarcinoma stage III and IV treated by a combination of adriamycin, cyclophosphamide, 5-fluorouracil and cis-DDP. Therapeutic role of cis-DDP in this combination].
    Pouillart P; Bretaudeau B; Palangie T; Jouve M; Garcia-Giralt E; Asselain B
    Bull Cancer; 1982; 69(5):434-42. PubMed ID: 6891903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Two elderly patients with advanced gastric cancer responding to chronomodulation chemotherapy with tegafur + cisplatin + isovorin followed by oral administration of S-1].
    Kobayashi A; Yamaguchi M
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):1003-7. PubMed ID: 11478129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.